Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.35 | N/A |
| PEG Ratio (TTM) | -3.84 | N/A |
| P/S Ratio (TTM) | 4.69 | N/A |
| P/B Ratio (TTM) | 0.95 | N/A |
| P/FCF Ratio (TTM) | 10.56 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.46 | N/A |
| Price to 5YR AVG FCF Ratio | 10.40 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.78% | N/A |
| ROE (TTM) | 7.24% | N/A |
| Net Profit Margin (TTM) | 35.16% | N/A |
| ROIC 5YR AVG | 11.29% | N/A |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.81% | 0.76% | 0.77% |
| Revenue | 490.48% | -0.03% | 1.31% |
| Net Income | -0.92% | 0.70% | 0.47% |
| Cash Flow | 20.73% | -6.39% | 0.88% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.72 | N/A |
| Quick Ratio (TTM) | 5.72 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | 0.73 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.36 | N/A |
| LTL to 5YR AVG FCF | 0.73 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.29% | N/A |